PetMeds® , a leading online provider of pet medications and wellness products, has announced a significant strategic move with the agreement to acquire PetCareRx, a company specializing in pet prescriptions and supplies. This all-cash transaction, valued at $36 million, is expected to finalize in the first quarter of this year and marks a pivotal step in PetMeds® ‘s strategy to broaden its market presence and accelerate growth beyond its core prescription services.
The acquisition is poised to significantly expand the addressable market for PetMeds® , injecting immediate, year-over-year growth into the business. CEO Matt Hulett highlighted that this move allows PetMeds® to swiftly venture into new categories, including premium food, supplements, treats, and a wider array of pet supplies. PetCareRx brings an impressive catalog of 10,000 items, more than tripling PetMeds® ‘s current offering of 3,000 Stock Keeping Units (SKUs). Currently, approximately 90% of PetMeds® ‘s revenue is generated from prescription medicines.
“In particular, what we haven’t done previously is food,” Hulett stated. “This gets us into premium and prescription food.” The expansion into food and other consumable products is anticipated to foster more frequent customer engagement, thereby increasing customer lifetime value and enhancing customer loyalty. PetCareRx also contributes a substantial base of 200,000 customers and generates $42 million in annual revenue, which will be integrated into the PetMeds® platform. PetMeds® plans to maintain the consumer-facing PetCareRx e-commerce brand as a distinct entity.
Jeanette Loeb, CEO of PetCareRx, expressed optimism about the union, stating, “joining forces with PetMeds® will enable a more holistic pet wellness experience with greater resources and scale.” PetMeds® is scheduled to discuss the transaction further during an analyst day webcast and conference call on January 19. The company projects that this acquisition will propel its revenue growth beyond the industry average, which is currently forecasted at 15% annually.
This strategic acquisition follows closely on the heels of a partnership established nine months prior with Vetster, a pet telehealth company. In that agreement, PetMeds® acquired a minority stake in Vetster, granting Vetster access to PetMeds® ‘s extensive network of 2 million pet owners and 70,000 veterinarians. When this partnership was announced in April 2022, Hulett indicated it was part of his broader strategy to unlock growth and position PetMeds® as a comprehensive pet health expert, moving beyond simply filling prescriptions.
PetMeds® , a publicly traded company based in Delray Beach, FL, has a 26-year history. For much of its existence, it operated as a low-growth, high-dividend yield company characterized by stable revenue and a loyal customer base. Hulett’s appointment as CEO in 2021 signaled a shift in strategy, with a clear objective to transform PetMeds® into a growth-oriented enterprise.
“We’re a small cap, profitable ecommerce company. There’s not many of those in the world,” Hulett remarked. He further elaborated on the company’s sustained presence in the pet prescription market by referencing the “strategic moat” surrounding this niche. “There’s a lot of logistics,” Hulett explained. “You have to be regulated in all 50 states. We get physical vet authorizations for every order that’s prescription-based. So we’re in the harder part of ecommerce retail.” PetMeds® positions itself as the largest pure-play online pharmacy, differentiating itself from competitors like Chewy, which, while possessing a substantial pharmacy operation, often relies on outsourcing, unlike larger retailers such as Target and Walmart.
Hulett believes this expansion into broader pet wellness offerings will create significant future opportunities. “I think its going to be a big opportunity for PetMeds® in the future because as we start addressing other things for our customers – care, wellness, medication, and diet – it’s going to enable us to grow the business,” he stated. He also noted that the prescription pet medication space is a complex area that many large online retailers are hesitant to enter. In contrast, major pet retailers such as Chewy, Petco, and PetSmart are actively competing to become the ultimate one-stop shop for pet owners, which includes offering pet medicines and prescriptions. PetSmart launched its online pharmacy in 2021, Petco is expanding its network of in-store veterinary clinics, and Chewy is incentivizing veterinarians to direct prescriptions through its platform.
The acquisition of PetCareRx by PetMeds® signifies a strategic evolution for the company, aiming to provide a more comprehensive and integrated approach to pet wellness, encompassing not just prescriptions but also a wider range of high-quality food, supplements, and supplies. This move is expected to enhance customer engagement and solidify PetMeds® ‘s position as a trusted resource for pet owners seeking a holistic approach to their pets’ health.